Disc Medicine, Inc.

NASDAQ:IRON

Biotechnology

Healthcare
$77.98 -0.03%

-$0.02 today

Market cap
$2.99B
Beta
2.10
P/E (TTM)
-11.2
EPS (TTM)
-$6.28
52W Low $40.00High $99.50

Volume 0.95M

Average 0.47M

IRON Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Disc Medicine, Inc.NASDAQ: IRON

Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026

Cash & equivalents falls 36.0% from a year ago

Cash & equivalents stood at $89.98M at the end of Q3 FY2026, down 36.0% from a year earlier and down 8.8% from the prior quarter. Over 3 fiscal years it compounded at -22.3% a year.

Context

  • Cash & equivalents amounted to 12.9% of total assets at the end of Q3 FY2026, down 9.4 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -36.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$89.98M-8.8% QoQ
Last fiscal yearDec 2025
$91.15M-52.6% YoY
Year agoSep 2025
$140.66M-36.0% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-36.0%——
1 year-52.6%——
3-year CAGR-22.3%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
91.15M USD
Year-over-year change
-52.6%
4-year CAGR
+0.9%

Cash & Equivalents vs competitors

How IRON compares with its peers on the latest reported figures

  • IRON's Sep 2026 cash & equivalents of $89.98M is the 5th highest of the 6 companies compared; the peer median is $237.37M.
  • Its year-over-year change of -36.0% is the lowest of 5, against a peer median of +96.6%.
  • Cash & equivalents amounts to 12.9% of total assets for IRON, versus a peer median of 47.4%.
IRON Competitors Peer median
Cash & Equivalents for IRON and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
DMRADamora Therapeutics, Inc.Mar 2026$532.9M +4363.5%+98.8%99.5%
PTGXProtagonist Therapeutics, Inc.Jun 2026$420.08M +149.2%+0.7%47.4%
COAGHemab Therapeutics Holdings, Inc. Common StockJun 2026$237.37M ——50.7%
AGIOAgios Pharmaceuticals, Inc.Mar 2026$113.6M +43.9%-13.8%9.6%
IRONDisc Medicine, Inc.Sep 2026$89.98M -36.0%-22.3%12.9%
GERNGeron CorporationMar 2026$70.78M -15.5%+11.8%13.3%
Peer median (excluding IRON) $237.37M+96.6%+6.2%47.4%

Competitors are the stored peer set for IRON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents88.04M194.61M360.38M192.43M91.15M
Short-term Investments000297.45M700.01M
Net Receivables00000
Inventory00000
Other Current Assets(802K)003.73M12.75M
Total Current Assets90.48M198.49M365.66M493.62M803.9M
Property, Plant & Equipment (Net)1.75M1.6M2.1M2.32M2.26M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets180K116K234K838K726K
Total Non-current Assets1.93M1.71M2.33M3.16M2.98M
Total Assets92.41M200.21M368M496.77M806.88M
Account Payables2.56M16.16M12.63M7.95M9.02M
Short-term Debt5M000611K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.45M3.62M5.79M7.21M27.01M
Total Current Liabilities13.42M22.58M21.44M23.32M36.64M
Long-term Debt404K0028.32M1.25M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities141.45M00029.16M
Total Non-current Liabilities143.19M1.03M1.44M29.87M30.41M
Total Liabilities156.61M23.61M22.88M53.19M67.05M
Common Stock02K2K3K4K
Retained Earnings(65.39M)(112.22M)(188.65M)(298M)(510.19M)
Accumulated OCI000289K965K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(64.2M)176.6M345.12M443.59M739.83M
Total Debt7.06M1.33M2.1M30M1.86M
Net Debt(80.98M)(193.28M)(358.28M)(162.43M)(89.28M)

Disc Medicine, Inc.

NASDAQ:IRON

Intrinsic Alpha fair value

Locked

Current Price

$77.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.